INTAS launches THYMOTAS - a patented, powerful immuno-booster add-on to standard COVID-19 treatment.
Binish Chudgar wins Ernst & Young "Entrepreneur of the Year 2018" award in Lifesciences and Healthcare category
Intas pharmaceuticals to be the first to launch pegfilgrastim biosimilars in europe
Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland
Intas lowers cancer treatment cost by 60%
Intas becomes the first Indian company to launch Biosimilar in the EU
Intas acquires Hospital Business in Spain and Portugal
Intas launches Azacitidine molecule in India
Intas completes sale of ChrysCapital's stake to Temasek
Intas launches rituximab
Corporate House, Near Sola Bridge,S. G.
Highway, Thaltej, Ahmedabad – 380054.
+91 79 6157 7000